American Healthcare REIT (NYSE: AHR) raised its full-year 2026 financial outlook after first-quarter results showed a ninth consecutive quarter of double-digit same-store net operating income (NOI) growth, driven by strong performance in its senior housing and integrated health campus portfolios.
"The results were aided by a strategic shift toward high-quality Medicare Advantage payors and improved quality mix," management noted in its Q1 2026 earnings report, highlighting that its Trilogy integrated senior health campus segment saw margins surpass 20% for the first time since the pandemic.
The company increased its full-year 2026 guidance for same-store NOI growth to a range of 9% to 12% and boosted its Normalized Funds From Operations (NFFO) per share forecast to between $2.09 and $2.30. The balance sheet also strengthened, with net debt to annualized EBITDA declining to 3.0x from 3.4x at the end of 2025.
AHR's performance points to the power of its strategy amid a demographic wave of residents aged 80 and above, coupled with historically low new supply in the senior housing market. This dynamic allows each incremental dollar of revenue to flow through at disproportionately higher margins, positioning the REIT for continued earnings growth as it executes on a $650 million acquisition pipeline.
AHR's outperformance is anchored in its two core segments. The Trilogy integrated senior health campuses are benefiting from a focus on higher-quality Medicare Advantage payors, which has lifted segment margins above 20%. In its Senior Housing Operating Portfolio (SHOP), the company has optimized its bottom line through dynamic revenue management and a 20% reduction in move-in referral fees.
Management emphasized an "operator-first" underwriting philosophy, prioritizing long-term cash flow durability through off-market relationships over chasing initial yield. This approach is building operating leverage as occupancy pushes higher across the portfolio. The company's development strategy remains focused on opening three to four new Trilogy campuses annually, particularly in CON-protected states like Wisconsin, to build a competitive moat.
AHR has significantly de-risked its external growth plans by strengthening its balance sheet. The reduction of its net debt to annualized EBITDA ratio to 3.0x provides substantial "dry powder" for acquisitions. To fund this, the company utilized its at-the-market (ATM) program to secure $527.4 million in gross proceeds through forward sale agreements.
This liquidity is further supported by a recently amended unsecured revolving credit facility, which increased capacity to $800 million and extended the maturity to April 2030. The combination of a fortified balance sheet and a clearly defined pipeline of deals with existing trusted operators underpins the company's confident outlook for the remainder of 2026.
This article is for informational purposes only and does not constitute investment advice.
